Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06535932 · ClinicalTrials.gov registry record · NA
Amara View Benchmark Study
A NA study, sponsored by Philips Clinical & Medical Affairs Global.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT06535932 is a NA study that has completed, run by Philips Clinical & Medical Affairs Global. The registered enrollment target is 35 participants.
The verdict
NCT06535932, a NA study, has completed, sponsored by Philips Clinical & Medical Affairs Global.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
This randomized crossover, benchmark clinical trial aims to compare the Philips Amara View and ResMed AirFit F40 minimal contact full face masks on patient preference of mask attributes and usage parameters. At the first study visit participants will be fitted with either the Amara View or the AirFit F40. The order in which participants will use the masks will be randomized. After the fitting and completion of informed consent, eligibility, and baseline questionnaires, participants will take home the first mask and use it with their prescribed PAP device for 15-days. After the first 15-day time period participants will return for their second visit. At this visit participants will return the first mask to the study team and complete a survey on the mask attributes. They will then be fitted with the second study mask and will be given the mask to take home and use with their prescribed PAP device for 15-days. At the end of the second 15-day trial period, participants will return for the third study visit. At this visit they will return the second mask and complete a mask attributes survey on the second mask.
Interventions
- DEVICE Amara View Minimal Contact Full Face Mask
- DEVICE F40 Minimal Contact Full Face Mask
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2024-07-25 |
| Est. Completion | 2024-09-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06535932
The ClinicalTrials.gov registry entry for NCT06535932 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philips Clinical & Medical Affairs Global, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Amara View Minimal Contact Full Face Mask is the first listed.
NCT06535932 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06535932 about?
NCT06535932 is a clinical study titled "Amara View Benchmark Study". This randomized crossover, benchmark clinical trial aims to compare the Philips Amara View and ResMed AirFit F40 minimal contact full face masks on patient preference of mask attributes and usage parameters. At the first study visit participants will be fitted with either the Amara View or the AirFi...
What is the current status of trial NCT06535932?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2024-07-25. Estimated completion is 2024-09-06.
What interventions are being tested in trial NCT06535932?
The interventions under investigation include: Amara View Minimal Contact Full Face Mask (DEVICE), F40 Minimal Contact Full Face Mask (DEVICE).
Who is sponsoring clinical trial NCT06535932?
This trial is sponsored by Philips Clinical & Medical Affairs Global, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.